NEW YORK (GenomeWeb) – After three straight years of declining mergers and acquisitions in the molecular diagnostics and omics life science tools space, 2015 was the year M&As came roaring back. The sector saw a 33 percent increase in deals, with Roche continuing the buying spree it started in 2014 and Merck KGaA closing its $17 billion acquisition of Sigma-Aldrich.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.